Evidence mapPaperPMID 36655379Full record

ReviewDiabetes, obesity & metabolism2023

The role of dietary salt in metabolism and energy balance: Insights beyond cardiovascular disease.

Qi Wu, George Burley, Li-Cheng Li, Shu Lin, Yan-Chuan Shi

Open access · hybridAbstract readReview
In one paragraph

Review in Diabetes, obesity & metabolism, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
8.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Qi WuObesity and Metabolic Disease Research Group, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.ORCID 0000-0003-3248-8322
George BurleyObesity and Metabolic Disease Research Group, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.ORCID 0000-0002-2560-3604
Li-Cheng LiCentre of Neurological and Metabolic Research, the Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.ORCID 0000-0001-7195-3624
Shu LinObesity and Metabolic Disease Research Group, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.ORCID 0000-0002-4239-2028
Yan-Chuan ShiObesity and Metabolic Disease Research Group, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.ORCID 0000-0002-8368-6735
Fujian Medical University · CNGarvan Institute of Medical Research · AU

Funding

Diabetes Australia Research Program Y22G-ShiYNational Health & Medical Research Council, Australia 1144286National Health & Medical Research Council, Australia 1162276
6 · The paper itself

Abstract

Dietary salt (NaCl) is essential to an organism's survival. However, today's diets are dominated by excessive salt intake, which significantly impacts individual and population health. High salt intake is closely linked to cardiovascular disease (CVD), especially hypertension, through a number of well-studied mechanisms. Emerging evidence indicates that salt overconsumption may also be associated with metabolic disorders. In this review, we first summarize recent updates on the mechanisms of salt-induced CVD, the effects of salt reduction and the use of salt substitution as a therapy. Next, we focus on how high salt intake can impact metabolism and energy balance, describing the mechanisms through which this occurs, including leptin resistance, the overproduction of fructose and ghrelin, insulin resistance and altered hormonal factors. A further influence on metabolism worth noting is the reported role of salt in inducing thermogenesis and increasing body temperature, leading to an increase in energy expenditure. While this result could be viewed as a positive metabolic effect because it promotes a negative energy balance to combat obesity, caution must be taken with this frame of thinking given the deleterious consequences of chronic high salt intake on cardiovascular health. Nevertheless, this review highlights the importance of salt as a noncaloric nutrient in regulating whole-body energy homeostasis. Through this review, we hope to provide a scientific framework for future studies to systematically address the metabolic impacts of dietary salt and salt replacement treatments. In addition, we hope to form a foundation for future clinical trials to explore how these salt-induced metabolic changes impact obesity development and progression, and to elucidate the regulatory mechanisms that drive these changes, with the aim of developing novel therapeutics for obesity and CVD.

Indexed as

Cardiovascular DiseasesDietEnergy MetabolismHumansObesitySodium Chloride, DietarySodium Chloride, Dietarycardiovascular disease (CVD)dietary salt (NaCl)energy balancemetabolic syndromemetabolismobesitysalt reductionsalt substitutionsodium intakethermogenesis

Identifiers

PMID36655379
PMCPMC10946535
OpenAlexW4317476183

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.